Shares of UnitedHealth Group Incorporated (NYSE:UNH) have been assigned an average rating of “Buy” from the twenty-seven ratings firms that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and twenty-four have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $215.83.
A number of analysts have recently weighed in on the company. Sanford C. Bernstein reiterated an “outperform” rating and set a $210.00 target price (up from $190.00) on shares of UnitedHealth Group in a research report on Saturday, July 22nd. Jefferies Group LLC reiterated a “buy” rating and set a $215.00 target price on shares of UnitedHealth Group in a research report on Friday, August 18th. Cowen and Company reiterated an “outperform” rating and set a $220.00 target price (up from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 target price for the company in a research report on Tuesday, August 1st. Finally, BMO Capital Markets assumed coverage on UnitedHealth Group in a research report on Monday, October 16th. They set an “outperform” rating and a $250.00 target price for the company.
TRADEMARK VIOLATION NOTICE: This report was originally published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://www.chaffeybreeze.com/2017/11/19/unitedhealth-group-incorporated-unh-receives-average-recommendation-of-buy-from-analysts.html.
In other news, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the sale, the director now directly owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. In the last three months, insiders sold 72,606 shares of company stock valued at $14,308,783. Insiders own 0.89% of the company’s stock.
UnitedHealth Group (NYSE UNH) traded down $1.23 on Friday, reaching $209.90. The company had a trading volume of 1,881,773 shares, compared to its average volume of 2,683,520. The company has a market cap of $203,407.36, a P/E ratio of 21.86, a PEG ratio of 1.56 and a beta of 0.64. UnitedHealth Group has a twelve month low of $148.56 and a twelve month high of $213.93. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. The firm had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company’s revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the company posted $2.17 EPS. sell-side analysts predict that UnitedHealth Group will post 9.99 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be paid a $0.75 dividend. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 annualized dividend and a dividend yield of 1.43%. UnitedHealth Group’s payout ratio is 33.26%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.